Role of Gut Microbiota and Postbiotics for Colorectal Cancer Advancing Therapeutic Strategies /
The emerging role of gut microbiota and postbiotics has implications for the management of not only human health and diseases, but also colorectal cancer in particular, as these elements influence colorectal cancer pathogenesis, treatment, and prevention. This book bridges the gap between cutting-ed...
Sparad:
| Institutionell upphovsman: | |
|---|---|
| Övriga upphovsmän: | , , |
| Materialtyp: | Elektronisk E-bok |
| Språk: | engelska |
| Publicerad: |
Cham :
Springer Nature Switzerland : Imprint: Humana,
2025.
|
| Upplaga: | 1st ed. 2025. |
| Serie: | Cancer Drug Discovery and Development,
|
| Ämnen: | |
| Länkar: | https://doi.org/10.1007/978-3-031-86065-2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-86065-2 | ||
| 003 | DE-He213 | ||
| 005 | 20260706115830.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 250702s2025 sz | s |||| 0|eng d | ||
| 020 | |a 9783031860652 |9 978-3-031-86065-2 | ||
| 024 | 7 | |a 10.1007/978-3-031-86065-2 |2 doi | |
| 050 | 4 | |a RC261-271 | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 072 | 7 | |a MED062000 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 thema | |
| 082 | 0 | 4 | |a 571.978 |2 23 |
| 082 | 0 | 4 | |a 616.02774 |2 23 |
| 245 | 1 | 0 | |a Role of Gut Microbiota and Postbiotics for Colorectal Cancer |h [electronic resource] : |b Advancing Therapeutic Strategies / |c edited by Neeraj Mishra, Ashish Garg, Sumel Ashique. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Humana, |c 2025. | |
| 300 | |a XI, 491 p. 31 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b PDF/UA-1 |2 onix | |
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Cancer Drug Discovery and Development, |x 2196-9914 | |
| 505 | 0 | |a Introduction to Gut Microbiota & Postbiotics: Health benefits to human being -- Introduction to Gut Microbiota and its Role in Health and Disease -- Molecular mechanisms of postbiotics in colorectal cancer -- Postbiotics, Metabolic Signalling in colorectal Cancer -- Gut Microbiota and colorectal cancer Pathogenesis -- Gut-microbiota in colorectal Cancer: Fundamentals, analytical techniques and its limitation -- Postbiotics: Bioactive Compounds and Their Effects -- Impact of Diet, Microbiota, and Postbiotics in Colorectal Cancer Management -- The Interplay Between modulation strategies of Gut Microbiota and Colorectal Cancer Development -- The Interplay Between Postbiotics and Colorectal Cancer -- Postbiotics and Colorectal Cancer: Current Research and Clinical Insights -- Gut-Brain Axis and Colorectal cancer: Neuroimmune interactions -- Gut Microbiota, Postbiotics, and Personalized Medicine in CRC -- Therapeutic Strategies of Targeting Gut Microbiota in Colorectal Cancer (CRC) Management -- Integrating Probiotics and Nanotechnology for Enhanced Treatment Efficacy in Colorectal Cancer -- Postbiotics, Gut Microbiota, and Colorectal Cancer: Implications for Immunotherapy -- Microbiota-Targeted Therapies for Colorectal Cancer: Current Challenges and Future Directions -- Diagnostic Approaches for Colorectal Cancer: Gut Microbiota-Based Biomarkers for Colorectal Cancer Detection and Monitoring -- Beyond Treatment: Integrating Gut Microbiota and Postbiotics Survivorship and Long-term Management of Colorectal Cancer -- Future Perspectives: Advancements in postbiotics & Gut Microbiota Research and Potential Therapeutic Breakthroughs. | |
| 520 | |a The emerging role of gut microbiota and postbiotics has implications for the management of not only human health and diseases, but also colorectal cancer in particular, as these elements influence colorectal cancer pathogenesis, treatment, and prevention. This book bridges the gap between cutting-edge research and practical clinical applications in the management of colorectal cancer by offering a fresh perspective on potential therapeutic strategies and exploring the significance of microbiota in the oncology landscape. Chapters delve into the specific impacts of postbiotics, linking them to immune response modulation, inflammation reduction, and direct anticancer effects. Chapters also explore current and emerging therapies, including the manipulation of gut microbiota and the use of postbiotics supplements. Clinical trial results, case studies, and expert opinions are interwoven to present a realistic view of the benefits, limitations, and future prospects of these innovative therapeutic strategies. This book is rounded out with perspectives on future research directions in this area, discussing potential next-generation therapies such as personalized medicine approaches and biotechnological advancements, and further contemplating broader implications of microbiota research on public health strategies. Informative and engaging, this book provides clinicians and researchers alike with a deeper understanding of how postbiotics can be harnessed in colorectal cancer treatment and potentially, the treatment of other cancers influenced by gut health. | ||
| 532 | 8 | |a Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | |a Cancer. | |
| 650 | 0 | |a Microbiology. | |
| 650 | 0 | |a Cytology. | |
| 650 | 0 | |a Gastroenterology. | |
| 650 | 1 | 4 | |a Cancer Microenvironment. |
| 650 | 2 | 4 | |a Cellular Microbiology. |
| 650 | 2 | 4 | |a Gastroenterology. |
| 700 | 1 | |a Mishra, Neeraj. |e editor. |0 (orcid)0000-0001-9127-4469 |1 https://orcid.org/0000-0001-9127-4469 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Garg, Ashish. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Ashique, Sumel. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031860645 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031860669 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031860676 |
| 830 | 0 | |a Cancer Drug Discovery and Development, |x 2196-9914 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-86065-2 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 912 | |a ZDB-2-237 | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 950 | |a Focus Bundle Biomedical and Human Health Sciences (SpringerNature-85407) | ||